Latest NewsJulphar Announces Robust Q2 2022 Results Marking a Return to Profitability
Latest NewsJulphar and Huadong Medicine Announce Strategic Cooperation of Liraglutide in the Middle East and North Africa Market.
Latest NewsUAE Ministry of Industry and Advanced Technology MoIAT Reviews Julphar state-of-the-art Insulin Production Facility in Ras Al Khaimah.
Latest NewsJulphar Takes part in the UAE-Egyptian Business Meeting In Abu Dhabi headed by the Egyptian Prime Minister
Latest NewsGulf Pharmaceutical Industries Julphar announces Q1 2022 results and delivers robust top and bottom line growth
Latest NewsJulphar Holds Annual General Meeting for the Year Ending 31 December 2021